Slottsviken Fastighetsaktiebolag (publ) (SLOTT.B)

Overview

Slottsviken Fastighetsaktiebolag (publ) is a distinguished real estate firm engaged in the acquisition, development, and management of properties both within Sweden and on an international scale. The genesis of this company can be traced back to the year 1983, hallmarking a significant presence in the real estate industry. Initially known as Conpharm AB (publ), the organization underwent a pivotal rebranding in July 2015, adopting the name Slottsviken Fastighetsaktiebolag (publ) to better reflect its expanded focus and aspirations. Headquartered in the vibrant city of Gothenburg, Sweden, Slottsviken stands as a testament to innovation and growth in the real estate sector.

Products and Services

• Residential Properties

Slottsviken Fastighetsaktiebolag (publ) holds a robust portfolio of residential properties, showcasing a wide array of living spaces designed to meet the diverse needs and preferences of its clientele. From modern apartments to traditional houses, the company prides itself on providing high-quality living environments that cater to various lifestyles.

• Commercial Premises

The company’s commercial real estate portfolio encompasses a broad spectrum of premises suitable for a multitude of business activities. These include spaces for:

• Production
• Shop/Trade
• Restaurants
• Industry
• Workshops
• Logistics
• Offices
Placing a strong emphasis on strategic location and functional design, Slottsviken ensures that each property serves as an optimal foundation for successful business operations.
• Investments in Securities

Apart from its core real estate operations, Slottsviken Fastighetsaktiebolag (publ) diversifies its investment portfolio by engaging in the securities market. This facet of the business allows the company to leverage financial instruments to maximize returns and contribute to its overall financial health and stability.

• Intellectual Property Management

Slottsviken Fastighetsaktiebolag (publ) is also invested in the management and ownership of intellectual property rights related to Reumacon and Wartec life science activities. This involvement underscores the company’s commitment to innovation and its strategic intent to explore and develop opportunities beyond traditional real estate ventures.